Sustained Therapies aims to drastically reduce humanity's reliance on antibiotics and to develop a simpler, more sustainable way to combat bacterial and viral diseases in global livestock production and crop plants.

The company's antibacterial solutions are based on highly specific bacteriophages targeting key bacterial diseases in fauna and flora.

These are combined with antiviral solutions using gene editing and silencing (RNAi).

The solutions can be applied in poultry, aquaculture, and plants and are classified as biopesticides.

Sustained Therapies is an AgChimedes Group company.